Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
66 hedge funds and large institutions have $252M invested in Applied Therapeutics in 2020 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 17 closing their positions.
1.06% more ownership
Funds ownership: 53.29% → 54.34% (+1.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 21
10% less funds holding
Funds holding: 73 → 66 (-7)
40% less capital invested
Capital invested by funds: $422M → $252M (-$169M)
41% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 17
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$9.88M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.83M |
| 3 |
O
OrbiMed
New York
|
+$8.55M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$3.91M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$3.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$10.1M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$6.82M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$6.58M |
| 4 |
Citigroup
New York
|
-$3.64M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.31M |
APLT Hedge Fund Activity: Q3 2020 in Review
66 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q3 2020, worth a combined $252M — down 40% from $422M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of APLT and 10 opened new positions — a net loss of 7 holders — while 21 trimmed existing stakes and 21 added.
The largest buyer was Artal Group, opening a new position worth an estimated $9.88M. The largest seller was Deerfield Management, exiting entirely with an estimated $10.1M sold.
- 66 institutional investors held Applied Therapeutics (APLT) as of Q3 2020, down from 73 in Q2 2020.
- Funds reported $252M of Applied Therapeutics stock for Q3 2020, down 40% quarter-over-quarter.
- 10 funds opened new Applied Therapeutics positions in Q3 2020 and 17 closed out, a net change of -7 holders.
- The largest Applied Therapeutics buyer in Q3 2020 was Artal Group, an estimated $9.88M added.
- The largest Applied Therapeutics seller in Q3 2020 was Deerfield Management, an estimated $10.1M sold.
Based on aggregated 13F filings for Q3 2020.